- Stage III uterine serous carcinoma: modern trends in multimodality treatment
-
Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz PE, Damast S
- KMID: 2511964
- J Gynecol Oncol.
- 2020 Jul;31(4):e53.
- doi: 10.3802/jgo.2020.31.e53
Objective: To examine outcomes in a modern treatment era for stage III uterine serous carcinoma (USC). Methods: Fifty women were retrospectively identified as 2009 International Federation of Gynecology and Obstetrics stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Financial toxicity in patients with gynecologic malignancies: a cross sectional study
-
Zeybek B, Webster E, Pogosian N, Tymon-Rosario J, Balch A, Altwerger G, Clark M, Menderes G, Huang G, Azodi M, Ratner ES, Schwartz PE, Santin AD, Andikyan V
- KMID: 2526281
- J Gynecol Oncol.
- 2021 Nov;32(6):e87.
- doi: 10.3802/jgo.2021.32.e87
Objective To evaluate financial toxicity and assess its risk factors among patients with gynecologic cancers. Methods This is a cross sectional study that included 2 survey tools, as well as patient demographics, disease... -
- CITED
-
- Close
- SHARE
-
- Close
